Literature DB >> 7190073

Initiation of transcription in permeabilized Novikoff hepatoma cells.

B Samal, N R Ballal, H Busch.   

Abstract

Novikoff hepatoma cells, grown in monolayer cultures, when permeabilized by treatment with lysolecithin, incorporated 3H-UTP at a high rate for 2 hours at 25 degrees. The incorporation was inhibited by initiation inhibitors such as rifampicin AF/013, heparin and aurintricarboxylic acid. About 75% of RNA polymerase II, and 45% of RNA polymerase I activities were inhibited by rifampicin AF/013. In contrast, transcription in isolated nuclei was not inhibited either by rifampicin AF/013 or heparin. The permeabilized cells apparently retain the mechanisms for reinitiation in vitro and may be a useful model for studies on the effects of proteins on gene transcription.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7190073     DOI: 10.1016/0309-1651(80)90072-7

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  4 in total

1.  Control of activation of liver RNA polymerase I occurring after re-feeding of protein-depleted mice.

Authors:  L Haim; S Iapalucci-Espinoza; R Conde; M T Franze-Fernández
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

2.  RNA polymerase II transcripts as targets for 5-fluorouridine cytotoxicity: antagonism of 5-fluorouridine actions by alpha-amanitin.

Authors:  R Heimer; A C Sartorelli
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Aurintricarboxilic acid as a tool for investigating the template-bound and unbound forms of RNA polymerase I in permeabilized cells.

Authors:  S Iapalucci-Espinoza; L Haim; M T Franze-Fernández
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

4.  Specific in vitro initiation of transcription of simian virus 40 early and late genes occurs at the various cap nucleotides including cytidine.

Authors:  D Gidoni; C Kahana; D Canaani; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.